Standout Papers

cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with ... 1980 2026 1995 2010 356
  1. cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice. (1980)
    Schabel Fm, Trader Mw et al. PubMed

Citation Impact

2 by Nobel laureates 9 from Science/Nature 54 standout
Sub-graph 1 of 25

Citing Papers

Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Cushing's syndrome
2015 Standout
2 intermediate papers

Works of Corbett Th being referenced

Establishment of cross-resistance profiles for new agents.
1983
cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.
1980 Standout

Author Peers

Author Molecular Biology Oncology Organic Chemistry PRM Last Decade Papers Cites
Corbett Th 269 377 46 142 8 649
Ivan Lukšík 17 46
Langfeng Yu 31 34 9 522
Emre Özkumur 354 6 12 485
Shaomei Yang 221 52 37 16 20 465

All Works

Loading papers...

Rankless by CCL
2026